Standout Papers

BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact 2014 2026 2018 2022 374
  1. BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact (2014)
    Helen Rizos, Alexander M. Menzies et al. Clinical Cancer Research
  2. A scoping review of factors influencing the implementation of liquid biopsy for cancer care (2025)
    Gaston Arnolda, Lydia Warburton et al. Journal of Experimental & Clinical Cancer Research

Immediate Impact

9 by Nobel laureates 18 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
2025 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
4 intermediate papers

Works of Helen Rizos being referenced

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
2023
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma
2017
and 2 more

Author Peers

Author Last Decade Papers Cites
Helen Rizos 4013 3415 1233 1426 139 6.3k
Hubing Shi 5350 3374 1243 1187 79 7.2k
David Polsky 3840 3570 821 1117 123 6.6k
Joaquı́n Arribas 4553 4907 771 1505 127 8.8k
Hartmut Koeppen 4842 4897 1369 1692 115 9.0k
Paul D. Smith 4988 2398 540 1361 117 7.3k
Zachary A. Cooper 2583 2544 1266 616 76 4.7k
Anna C. Pavlick 4641 5666 2166 1146 216 8.7k
Andrew E. Aplin 5334 1858 1208 1204 117 7.7k
Mitchell P. Levesque 3473 2066 1228 691 162 5.8k
Carlos Garcı́a-Echeverrı́a 6665 2834 548 1132 130 9.0k

All Works

Loading papers...

Rankless by CCL
2026